| Ytd | -3.65% | |
| 1y | -5.68% |
| Open | 44.30 | Prev Close | 44.38 | Low | 43.32 | High | 44.31 | Mkt Cap | 8.95B |
| Vol | 1.75M | Avg Vol | 2.79M | EPS | 1.97 | P/E | 21.99 | Forward P/E | 16.59 |
| Beta | 0.63 | Short Ratio | 2.31 | Inst. Own | 79.12% | Dividend | 0.35 | Div Yield | 0.79 |
| Ex Div Date | 07-07 | Earning | 11-04 | 50-d Avg | 42.48 | 200-d Avg | 42.55 | 1yr Est | 46.27 |
VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today a
Qiagen N.V. (QGEN) Presents at 2026 Global Healthcare Conference Transcript
Qiagen N.V. (QGEN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Engineers Gate Manager LP grew its position in shares of Qiagen N.V. (NYSE: QGEN) by 107.7% in the u
10x Genomics won a $4.8 million patent infringement lawsuit against Qiagen subsidiary Parse Bioscien
Jury finds Parse willfully infringed Scale Biosciences' patents and rejects Parse's invalidi
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that Jonathan M. Pratt has b